论文部分内容阅读
当前,由于在国际上中医中药的疗效已逐渐为现代科学所证实,随之而来的中医药科技领域内的国际性竞争也就日益加剧。因此,要进一步加强我国中医药学在其科技研究方面的优势,其科技研究经费的投入也就成为中医药学科技体制改革的一个重要课题。 股份制是随着社会经济的进步而产生、发展起来的,其通过一定的形式向社会公众筹集资金,实现资本集中,用于扩大生产。值此,笔者谈一下股份制在中医药科技投资体系中的作用。1 股份制是中医药科技投资之重要方式 随着经济和科技体制改革的不断深化,我国科技投资已由过去单一“供给制”式的财政无偿拨款,转向了计划和市场经济相结合的资展趋势,使其在来源渠道,支持机制和
At present, as the curative effect of traditional Chinese medicine in the world has gradually been confirmed by modern science, the international competition in the field of Chinese medicine followed by it is also increasingly intensified. Therefore, it is necessary to further strengthen the advantages of Chinese medicine in its scientific and technological research, and its investment in science and technology research funding has become an important issue in the reform of the TCM science and technology system. The joint-stock system is created and developed with the progress of the social economy. It raises funds to the public through certain forms, and realizes the concentration of capital for the expansion of production. On this account, the author talked about the role of joint-stock system in the investment system of Chinese medicine science and technology. 1 Joint-stock system is an important way for TCM science and technology investment With the continuous deepening of the economic and technological system reforms, China’s S&T investment has shifted from a single “supply-based” fiscal provision in the past to a combination of planned and market-based investment trends. Make it in the source channel, support mechanisms and